Code
31519408
Duration
01 January 2008 → 31 December 2010
Funding
Research Foundation - Flanders (FWO)
Promotor
Research disciplines
-
Medical and health sciences
- Endocrinology and metabolic diseases
- Endocrinology and metabolic diseases
- Endocrinology and metabolic diseases
Keywords
evaluation
Multiple Sclerosis (MS)
Project description
The weight regulating hormone leptin plays a crucial role in the onset and progression of a series of T-cell mediated auto-immune diseases, like multiple sclerosis (MS). The aim of the project is to design and evaluate nanobodies, a relatively new technique based on the use of camel antibodies, directed against the leptin receptor in a relapsing-remitting MS model.